Brief

"On "08/11/2024", the "European Medicines Agency (EMA)" issued an update regarding "Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 November 2024". The CVMP adopted positive opinions on marketing authorisation applications for various veterinary medicinal products, including Carprofen Orion, MS-H Vaccine, Simparica Trio, and others.

This content is restricted.

Highlights content goes here...

This content is restricted.

European Medicines Agency (EMA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies